Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 February 2020 | Story Xolisa Mnukwa | Photo Sonia Small
T-systems funding
Opening the doors of opportunity – TSSA allocated R2,4 million in bursary funding for 200 UFS students.


It is no secret that higher education institutions all over South Africa are plagued with the burden of current and historical student debt, leaving many hopeful students with the risk of financial exclusion. T-Systems South Africa (TSSA) has contributed a substantial amount of R2,4 million to fund a total of 200 students at the University of the Free State (UFS) in order to address ‘skills shortages’ in South Africa.

TSSA, a local unit of T-Systems International – a subsidiary of Deutsche Telekom – is invested in capitalising on South African expertise where innovation and intellectual property of a global (Information and Communications Technology) ICT provider is involved. The company strives to transform their clients and South Africa as a whole by providing innovative ICT solutions that work, in South Africa and for South Africa.

The company aims to endorse inclusive transformation in South Africa through the promotion and implementation of skills and enterprise development, as well as job creation. This forms part of the company’s National Development Plan for 2030 that envisions the elimination of poverty and reduced inequality.

Kovsie Alumni Trust Investment

Through its corporate social-responsibility wing called the Nation Building Initiative, T-Systems identified the University of the Free State after being contacted by the Kovsie Alumni Trust (KAT). 

KAT identified this opportunity as a call for the university to aid the advancement of students through initiatives such as the Integrated Transformation Plan (ITP), which was first launched in 2017. The ITP aims to utilise the university’s core functions (routed in teaching and learning, research, and engaged scholarship) to train and mould students into globally competitive graduates, which essentially also build towards skills and enterprise development, together with job creation. 

“The contribution of funding from T-Systems enabled us to empower our honours students by paying their outstanding university debt for 2019.  This has had a significant impact on the lives of many of our honours students who will be able to enrol for master’s programmes or seek employment without the burden of university debt,” says Professor Corli Witthuhn, UFS Vice-Rector: Research, Innovation and Internationalisation. 

“The University of the Free State is looking forward to partnering with T-Systems in 2020 in order to ensure continued opportunities for our students to further their education.”


Addressing a skills shortage in South Africa

Kovsie students completing honours studies in fields such as technology, human resources, and marketing as well as qualifications routed in accounting and finance, were given preference for the bursary. Other senior students required a pass mark of 60% or more to qualify for the bursary. TSSA paid off the university debt of students selected in 2019, and they had the opportunity to reapply in 2020. The UFS Alumni office facilitated the process. 

In 2020, students from all study years will be considered for the bursary, including matriculants who are entering university for the first time.  

Dineo Molefe , Managing Director at TSSA, says: “T-Systems has always invested in education by running a number of developmental initiatives, among others its ICT Academy – which provides free learnerships, internship programmes, including a learnership for disabled people as well as the flagship Hazyview Digital Learning Centre, which has become a unique rural nearshoring success story.

“All of this is earmarked to address the serious shortage of ICT skills – and by developing those skills, we not only address an industry problem but also contribute to employment opportunities in South Africa.”

News Archive

Research contributes to improving quality of life for cancer patients
2016-11-21

Description: Inorganic Chemistry supervisors  Tags: Inorganic Chemistry supervisors

Inorganic Chemistry supervisors in the Radiopharmacy
Laboratory during the preparation of a typical complex
mixture to see how fast it reacts. Here are, from the left,
front: Dr Marietjie Schutte-Smith, Dr Alice Brink
(both scholars from the UFS Prestige
Scholar Programme), and Dr Truidie Venter (all three
are Thuthuka-funded researchers).
Back: Prof André Roodt and Dr Johan Venter.
Photo: Supplied

Imagine that you have been diagnosed with bone cancer and only have six months to live. You are in a wheelchair because the pain in your legs is so immense that you can’t walk anymore – similar to a mechanism eating your bones from the inside.

You are lucky though, since you could be injected with a drug to control the pain so effective that you will be able to get out of the wheelchair within a day-and-a-half and be able to walk again. Real-life incidents like these provide intense job satisfaction to Prof André Roodt, Head of Inorganic Chemistry at the University of the Free State (UFS). The research, which is conducted by the Inorganic Group at the UFS, contributes greatly to the availability of pain therapy that does not involve drugs, but improves the quality of life for cancer patients.

The research conducted by the Inorganic Group under the leadership of Prof Roodt, plays a major role in the clever design of model medicines to better detect and treat cancer.

The Department of Chemistry is one of approximately 10 institutions worldwide that conducts research on chemical mechanisms to identify and control cancer. “The fact that we are able to cooperate with the Departments of Nuclear Medicine and Medical Physics at the UFS, the Animal Research Centre, and other collaborators in South Africa and abroad, but especially the methodology we utilise to conduct research (studying the chemical manner in which drugs are absorbed in cancer as well as the time involved), enhances the possibility of making a contribution to cancer research,” says Prof Roodt.

Technique to detect cancer spots on bone
According to the professor, there are various ways of detecting cancer in the body. Cancer can, inter alia, be identified by analysing blood, X-rays (external) or through an internal technique where the patient is injected with a radioactive isotope.

Prof Roodt explains: “The doctor suspects that the patient has bone cancer and injects the person with a drug consisting of an isotope (only emits X-rays and does no damage to tissue) that is connected to a phosphonate (similar to those used for osteoporosis). Once the drug is injected, the isotope (Technetium-99m) moves to the spot on the bone where the cancer is located. The gamma rays in the isotope illuminate the area and the doctor can see exactly where treatment should be applied. The Technetium-99m has the same intensity gamma rays as normal X-rays and therefore operates the same as an internal X-ray supply.” With this technique, the doctor can see where the cancer spots are within a few hours.

The same technique can be used to identify inactive parts of the brain in Alzheimer patients, as well as areas of the heart where there is no blood supply or where the heart muscle is dead.

Therapeutic irradiation of cancer
For the treatment of pain connected with cancer, the isotope Rhenium-186 is injected. Similar to the manner in which the Technetium-99m phosphonate compound is ingested into the body, the Rhenium-186 phosphonate travels to the cancer spots. Patients thus receive therapeutic irradiation – a technique known as palliative therapy, which is excellent for treating pain. A dosage of this therapy usually lasts for about two months.

The therapy is, however, patient specific. The dosages should correspond with the occurrence and size of cancer spots in the patient’s body. First, the location of the cancer will be determined by means of a technetium scan. After that, the size of the area where the cancer occurs has to be determined. The dosage for addressing total pain distribution will be calculated according to these results.

Technique to detect cancer spots on soft tissue
Another technique to detect cancer as spots on bone or in soft tissue and organs throughout the body is by utilising a different type of irradiation, a so-called PET isotope. The Fluor-18 isotope is currently used widely, and in Pretoria a machine called a cyclotron was produced by Dr Gerdus Kemp, who is a former PhD graduate from the Inorganic Research Group. The F-18 is then hidden within a glucose molecule and a patient will be injected with the drug after being tranquillised and after the metabolism has been lowered considerably. The glucose, which is the ‘food' that cancer needs to grow, will then travel directly to the cancer area and the specific area where the cancer is located will thus be traced and ‘illuminated’ by the Fluor-18, which emits its own 'X-rays'.

In the late 80s, Prof Roodt did his own postdoctoral study on this research in the US. He started collaborating with the Department of Nuclear Medicine at the UFS in the early 90s, when he initiated testing for this research.

Through their research of more than 15 years, the Inorganic Group in the Department of Chemistry has made a major contribution to cancer research. Research on mechanisms for the detection of cancer, by designing new clever chemical agents, and the chemical ways in which these agents are taken up in the body, especially contributes to the development in terms of cancer therapy and imaging, and has been used by a number of hospitals in South Africa.

The future holds great promise
Prof Roodt and his team are already working on a bilateral study between the UFS and Kenya. It involves the linking of radio isotopes, as mentioned above, to known natural products (such as rooibos tea), which possess anti-cancer qualities.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept